GLP-1 Without Insurance: Your Real Options in 2026

Brand-name GLP-1 medications like Wegovy and Zepbound carry retail pharmacy prices of $1,000 to $1,400 per month without insurance. For most people, that's not realistic. A few things are worth knowing upfront: Novo Nordisk now offers Wegovy through a direct self-pay program starting at $199–$349/month (pen) or $149/month (pill) at wegovy.com, which is significantly lower than the retail pharmacy price. Eli Lilly sells Zepbound directly through LillyDirect at $299–$449/month for self-pay patients. And compounded semaglutide from licensed telehealth providers starts at $149/month. This guide covers all three paths so you can choose what fits your situation.

Option 1: Compounded semaglutide

Compounded semaglutide is produced by licensed compounding pharmacies using the same active ingredient as brand-name Wegovy and Ozempic. It is not FDA-approved as a finished product — an important distinction. But it's produced under FDA oversight when sourced from a 503B registered outsourcing facility, which means the pharmacy is subject to Current Good Manufacturing Practice (CGMP) standards (FDA 503B outsourcing facilities).

For patients paying out of pocket, cost is the defining advantage. Typical all-inclusive pricing from reputable telehealth providers runs $149 to $350 per month as of April 2026, depending on dose and provider — well below the retail pharmacy price for brand-name options.

Why is it cheaper? Compounding pharmacies don't go through FDA's full drug approval process, which carries enormous R&D and manufacturing costs. They also don't carry brand premiums. You're paying for the active ingredient and the compounding process, not a patented finished product.

What to look for in a provider:

• Confirm they use a licensed 503B compounding pharmacy. This is the most important quality signal.
• Ask whether they provide a certificate of analysis (CoA) for each batch.
• Avoid providers that add unauthorized additives such as B12 or cyanocobalamin without clinical justification. The FDA has flagged this practice as a safety concern (FDA safety communication).
• Confirm that the total price includes medication, supplies, and follow-up visits. Some providers charge these separately.

One regulatory note: compounded GLP-1s were widely available during the FDA-declared semaglutide shortage. Now that the FDA has resolved the shortage designation, the availability of compounded semaglutide from 503B facilities may change. Check with your provider about current availability in your state.

Option 2: Manufacturer savings programs

Novo Nordisk and Eli Lilly each offer savings programs for their GLP-1 medications. The programs are real, but the eligibility criteria mean most uninsured patients won't qualify.

Novo Nordisk Wegovy savings program: Novo Nordisk offers a savings card that may reduce Wegovy costs to as low as $25 per month for eligible commercially insured patients (Wegovy savings page). The catch: eligibility requires commercial insurance that covers Wegovy. Patients without insurance, or with Medicare or Medicaid coverage, are generally not eligible per the program terms. If you have employer-sponsored commercial insurance but a high copay, this is worth checking. Without any insurance, it is unlikely to apply.

Eli Lilly Zepbound savings card: Lilly's savings card program for Zepbound (tirzepatide) works similarly. Qualifying commercially insured patients may pay as little as $25 per fill (Zepbound savings page). Again, uninsured patients typically do not qualify. Lilly does offer Zepbound vials through its LillyDirect program at $299 to $449 per month for self-pay patients, which is a genuinely lower cash price than retail pharmacy — without requiring insurance.

The honest summary: if you have no insurance at all, manufacturer savings cards are designed for commercially insured patients and you will likely hit a wall. LillyDirect's self-pay vial pricing is the notable exception.

Option 3: GoodRx and cash-pay brand-name

GoodRx and similar pharmacy discount programs can reduce the cash price of Ozempic and Wegovy at participating pharmacies. With a GoodRx coupon, Ozempic (0.5mg, 2 pens) has been available for approximately $800 to $950 per month at some pharmacies, though prices vary by location and change frequently (GoodRx Ozempic pricing).

This is still expensive. But for patients who specifically want brand-name semaglutide, have no insurance, and can afford this range, it's a legitimate path. The steps are straightforward: search GoodRx for your medication and dose, find a participating pharmacy nearby, and present the coupon at pickup. GoodRx does not require a membership for basic coupons.

Wegovy's GoodRx price runs higher, typically $900 to $1,200 per month at cash pay, because the 2.4mg weight-loss indication carries a different pricing tier than Ozempic.

Providers that work well without insurance

These providers are consistently among the most cost-accessible options for uninsured patients based on pricing verified by RxPickr as of April 2026.

Provider	Monthly cost	Medication	Notes
Henry Meds	From $149/mo	Compounded semaglutide	All-inclusive: medication, visits, supplies
TrimRx	From $179/mo	Compounded semaglutide or tirzepatide	All-inclusive, licensed 503B pharmacy
Mochi Health	From $178/mo ($79 membership + $99 medication)	Compounded semaglutide	Flat medication price at any dose; dietitian access included
LillyDirect	$299–$449/mo	FDA-approved Zepbound (tirzepatide)	Direct from manufacturer; vial self-injection required
Found	Verify on site	Compounded semaglutide (verify availability)	Full behavioral coaching included — pricing structure subject to change

Henry Meds and TrimRx are the lowest-cost options on this list. The trade-off at both is minimal coaching. Mochi Health costs slightly more but includes dietitian access. LillyDirect is the only option on this list offering FDA-approved brand-name medication in this price range. Found's pricing and compounded semaglutide availability have changed — verify current offerings directly before signing up.

What to do next

Start by deciding whether compounded or brand-name is the right fit for you. If cost is the primary constraint and you've researched the regulatory context, compounded semaglutide from a licensed 503B provider is the most practical path for most uninsured patients. If you specifically want brand-name tirzepatide, LillyDirect's self-pay pricing is worth a direct look.

Before starting any GLP-1 medication, consult your healthcare provider. A telehealth clinician at any of the providers above can conduct a clinical evaluation and issue a prescription if you're a candidate, but GLP-1 medications require a prescription and medical supervision.

GLP-1 medications require a prescription from a licensed healthcare provider. Compounded medications are not FDA-approved as finished products. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or changing any medication.